These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands. Axelsen PH, Li D. Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223 [Abstract] [Full Text] [Related]
5. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini. Lee JG, Sagui C, Roland C. J Am Chem Soc; 2004 Jul 14; 126(27):8384-5. PubMed ID: 15237988 [Abstract] [Full Text] [Related]
7. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci. Lessard IA, Healy VL, Park IS, Walsh CT. Biochemistry; 1999 Oct 19; 38(42):14006-22. PubMed ID: 10529248 [Abstract] [Full Text] [Related]
9. Affinity capillary electrophoresis: a physical-organic tool for studying interactions in biomolecular recognition. Colton IJ, Carbeck JD, Rao J, Whitesides GM. Electrophoresis; 1998 Mar 19; 19(3):367-82. PubMed ID: 9551788 [Abstract] [Full Text] [Related]
10. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers. Cooper MA, Fiorini MT, Abell C, Williams DH. Bioorg Med Chem; 2000 Nov 19; 8(11):2609-16. PubMed ID: 11092546 [Abstract] [Full Text] [Related]
11. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding. Okano A, Nakayama A, Schammel AW, Boger DL. J Am Chem Soc; 2014 Oct 01; 136(39):13522-5. PubMed ID: 25211770 [Abstract] [Full Text] [Related]
14. Estimation of receptor-ligand interactions by the use of a two-marker system in affinity capillary electrophoresis. Mito E, Zhang Y, Esquivel S, Gomez FA. Anal Biochem; 2000 May 01; 280(2):209-15. PubMed ID: 10790302 [Abstract] [Full Text] [Related]
15. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D. Science; 1999 Apr 16; 284(5413):507-11. PubMed ID: 10205063 [Abstract] [Full Text] [Related]
16. Crystallization and preliminary X-ray crystallographic analysis of a vancomycin-N-acetyl-D-Ala-D-Ala complex. McPhail D, Cooper A, Freer A. Acta Crystallogr D Biol Crystallogr; 1999 Feb 16; 55(Pt 2):534-5. PubMed ID: 10089369 [Abstract] [Full Text] [Related]
17. Partitioning of vancomycin using poly(ethylene glycol)-coupled ligands in aqueous two-phase systems. Singh M, Clark WM. Biotechnol Prog; 1994 Feb 16; 10(5):503-12. PubMed ID: 7765375 [Abstract] [Full Text] [Related]
18. Discovery of high-affinity peptide ligands for vancomycin. Yao N, Wu CY, Xiao W, Lam KS. Biopolymers; 2008 Feb 16; 90(3):421-32. PubMed ID: 18260149 [Abstract] [Full Text] [Related]
19. Intermolecular forces and energies between ligands and receptors. Moy VT, Florin EL, Gaub HE. Science; 1994 Oct 14; 266(5183):257-9. PubMed ID: 7939660 [Abstract] [Full Text] [Related]